Focus On Cognitive Disorder Research Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Focus On Cognitive Disorder Research book. This book definitely worth reading, it is an incredibly well-written.
Focus on Cognitive Disorder Research by William P. Briscoe Pdf
Cognitive disorders are defined as those in which a limitation of cognitive functioning is the main feature. They include: amnestic disorders, Huntington's disease, and mental retardation, dementia, delirium, aphasia, and cognitive disorders not otherwise specified. This book brings together leading researchers from throughout the world.
Research Focus on Cognitive Disorders by Valerie N. Plishe Pdf
Cognitive disorders are defined as those in which a limitation of cognitive functioning is the main feature. They include: amnestic disorders, Huntington's disease, and mental retardation, dementia, delirium, aphasia, and cognitive disorders not otherwise specified. This book brings presents leading researchers from throughout the world.
National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Committee on Preventing Dementia and Cognitive Impairment
Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Committee on Preventing Dementia and Cognitive Impairment Publisher : National Academies Press Page : 181 pages File Size : 48,6 Mb Release : 2017-10-05 Category : Medical ISBN : 9780309459594
Preventing Cognitive Decline and Dementia by National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Committee on Preventing Dementia and Cognitive Impairment Pdf
Societies around the world are concerned about dementia and the other forms of cognitive impairment that affect many older adults. We now know that brain changes typically begin years before people show symptoms, which suggests a window of opportunity to prevent or delay the onset of these conditions. Emerging evidence that the prevalence of dementia is declining in high-income countries offers hope that public health interventions will be effective in preventing or delaying cognitive impairments. Until recently, the research and clinical communities have focused primarily on understanding and treating these conditions after they have developed. Thus, the evidence base on how to prevent or delay these conditions has been limited at best, despite the many claims of success made in popular media and advertising. Today, however, a growing body of prevention research is emerging. Preventing Cognitive Decline and Dementia: A Way Forward assesses the current state of knowledge on interventions to prevent cognitive decline and dementia, and informs future research in this area. This report provides recommendations of appropriate content for inclusion in public health messages from the National Institute on Aging.
Living with Mild Cognitive Impairment by Nicole D. Anderson,Kelly J. Murphy,Angela K. Troyer Pdf
"As you have grown older, you may have noticed changes in your memory. You might find yourself walking into a room and forgetting why you are there. It might be more difficult to remember the name of someone you just met. You may also notice that it takes longer to come up with words in conversation"--
National Research Council,Division of Behavioral and Social Sciences and Education,Board on Behavioral, Cognitive, and Sensory Sciences,Committee on Aging Frontiers in Social Psychology, Personality, and Adult Developmental Psychology
Author : National Research Council,Division of Behavioral and Social Sciences and Education,Board on Behavioral, Cognitive, and Sensory Sciences,Committee on Aging Frontiers in Social Psychology, Personality, and Adult Developmental Psychology Publisher : National Academies Press Page : 280 pages File Size : 49,8 Mb Release : 2006-02-13 Category : Social Science ISBN : 9780309164917
When I'm 64 by National Research Council,Division of Behavioral and Social Sciences and Education,Board on Behavioral, Cognitive, and Sensory Sciences,Committee on Aging Frontiers in Social Psychology, Personality, and Adult Developmental Psychology Pdf
By 2030 there will be about 70 million people in the United States who are older than 64. Approximately 26 percent of these will be racial and ethnic minorities. Overall, the older population will be more diverse and better educated than their earlier cohorts. The range of late-life outcomes is very dramatic with old age being a significantly different experience for financially secure and well-educated people than for poor and uneducated people. The early mission of behavioral science research focused on identifying problems of older adults, such as isolation, caregiving, and dementia. Today, the field of gerontology is more interdisciplinary. When I'm 64 examines how individual and social behavior play a role in understanding diverse outcomes in old age. It also explores the implications of an aging workforce on the economy. The book recommends that the National Institute on Aging focus its research support in social, personality, and life-span psychology in four areas: motivation and behavioral change; socioemotional influences on decision-making; the influence of social engagement on cognition; and the effects of stereotypes on self and others. When I'm 64 is a useful resource for policymakers, researchers and medical professionals.
Nearly 44 million people have Alzheimer’s or related dementia worldwide, according to the Alzheimer’s Disease International organization. That number is expected to double every 20 years. Unlike other books on the market, Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy covers recent advancements in cognitive, clinical, neural, and therapeutic aspects of Alzheimer’s and other forms of dementia. First, readers are introduced to cognitive and clinical studies, focusing on the different types of memory impairment, past and future thinking. This includes the prevalence of depression, its relationship to other symptoms, and the quality of life for those with Alzheimer’s disease. In addition, the book discusses recent studies on memory dysfunction in advanced-stage Alzheimer’s disease, in comparison to early-stage, including a chapter on the underlying factors in the transition from mild cognitive impairment to Alzheimer’s diagnosis. Following this section, the book presents recent studies on the role of different cortical and subcortical structures in the development of various symptoms in Alzheimer’s disease, as well as different neural biomarkers underlying the development and treatment of the disease. In the last section of the book, therapeutic aspects of Alzheimer’s disease, focusing on behavioral and pharmacological treatments of sleep disorders, memory problems, and depression, are reviewed. The book aids readers in understanding the advances in research and care, making it a prime tool for all clinicians, psychologists, researchers, neurologists, and caregivers of dementia patients. Reviews recent developments of cognitive and clinical studies Covers factors underlying the transition from mild cognitive impairment to Alzheimer’s disease Discusses different neural biomarkers underlying the development and treatment of Alzheimer’s disease Provides a comparison of the effectiveness of various types of treatments
Focus on Alzheimer's Disease Research by Eileen M. Welsh Pdf
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's disease (AD), which involves the parts of the brain that control thought, memory, and language. Age is the most important known risk factor for AD. The number of people with the disease doubles every 5 years beyond age 65. AD is a slow disease, starting with mild memory problems and ending with severe brain damage. The course the disease takes and how fast changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. Current research is aimed at understanding why AD occurs and who is at greatest risk of developing it, improving the accuracy of diagnosis and the ability to identify those at risk, discovering, developing, and testing new treatments, and discovering treatments for behavioural problems in patients with AD. This new book gathers state-of-the-art research from leading scientists throughout the world which offers important information on understanding the underlying causes and discovering the most effective treatments for Alzheimer's Disease.
Cognition in Parkinson's Disease, Volume 269 in the Progress in Brain Research series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Cognition in Prodromal Parkinson’s disease, The epidemiology of cognitive function in Parkinson's disease, Real-life consequences of cognitive dysfunction in Parkinson’s disease, Animal models of cognition in Parkinson’s disease, Functional neuroanatomy of cognition in Parkinson’s disease, Neuroimaging approaches to cognition in Parkinson’s disease, Cognitive dysfunction and neuropsychiatric aspects of Parkinson’s disease, Neuropsychology of Parkinson’s disease, Cholinergic Systems, Attentional-Motor Integration, and Cognitive Control in Parkinson Disease, and much more. Provides the authority and expertise of leading contributors from an international board of authors Presents the latest release in Progress in Brain Research series Updated release includes the latest information on Cognition in Parkinson's Disease
Cognitive Enhancement in CNS Disorders and Beyond by Dr Richard S.E. Keefe,Dr Avi (Abraham) Reichenberg,Dr Jeffrey Cummings Pdf
Cognitive Enhancement in CNS Disorders and Beyond compiles a series of educational and thought-provoking chapters from the world's leading cognitive and clinical scientists to describe the latest research on cognitive impairments in a host of pathological conditions that affect CNS functioning, what treatments are available for these impairments, and how new treatments are being tested. This volume will benefit any investigators in cognitive science and clinical research, but is also accessible to non-experts. It advances the field toward the availability of cognitive enhancing drugs and devices that will benefit those who need them most and others who may feel that these techniques can help them to thrive. There has never been a time that we knew more about cognition and never a time when cognition was more important to the functioning of human beings than right now. Psychological science and cognitive neuroscience have become the most popular endeavor of students world wide, is the focus of attention of our greatest scientific accomplishments and the emphasis of many publications in the mainstream media. Since humans depend on cognitive abilities for survival, quality of life, and productivity, improving it has never been more important. Those with impairments in key aspects of cognition suffer dearly, as they are unable to obtain and retain information, unable to make sound decisions based upon the information at hand, and unable to plan future activities. The availability of pharmacological and behavioral interventions that can improve cognitive abilities and provide impaired individuals with the social, occupational and functional quality of life that the rest of us enjoy has potential far-reaching implications. Such interventions can also benefit those who want to boost current cognitive abilities to higher levels, perhaps as a means to hone skills in providing products for others or to gain an edge on competition. There has never been a book devoted solely to describing the latest cognitive science and neuroscience on the methods for enhancing cognition in healthy and unhealthy humans. Cognitive Enhancement in CNS Disorders and Beyond accomplishes exactly that in a straightforward and accessible manner.
Cognitive Enhancement by Shira Knafo,César Venero Pdf
Cognitive Enhancement: Pharmacologic, Environmental and Genetic Factors addresses the gap that exists in research on the topic, gathering multidisciplinary knowledge and tools that help the reader understand the basics of cognitive enhancement. It also provides assistance in designing procedures and pharmacological approaches to further the use of novel cognitive enhancers, a field that offers potential benefit to a variety of populations, including those with neurologic and psychiatric disorders, mild aging-related cognitive impairment, and those who want to improve intellectual performance. The text builds on our knowledge of the molecular/cellular basis of cognitive function, offering the technological developments that may soon enhance cognition. Separate sections cover enhancement drugs, environmental conditions, and genetic factors in terms of both human and animal studies, including both healthy/young and aging/diseased individuals. Provides a multidisciplinary knowledge, enabling a further understanding of cognitive enhancement Offers coverage of the pharmacologic, environmental, and genetic factors relevant to the topic Discusses cognitive enhancement from the perspective of both healthy and diseased or aging populations Topics are discussed in terms of both human and animal studies
Neurocognition and Social Cognition in Schizophrenia Patients by V. Roder,A. Medalia Pdf
Research shows that neuro- and social cognition have a decisive influence on functional outcome in people with schizophrenia. In this publication, world-renowned experts summarize the latest research on approaches to assessing and treating cognition in schizophrenia. The book is organized to take the reader through the steps from definitions and assessment of cognition to research on the relevance of cognition in everyday life, to chapters which focus on treatments for cognitive disorders. The reader will learn about the NIMH MATRICS initiative which has provided clinicians and researchers with the tools to define and assess neuro- and social cognitive functioning in people with schizophrenia. Then the treatments for neuro and social cognitive deficits are discussed in several chapters which give an overview of cognitive remediation approaches, accompanied by concrete treatment examples. The reader will also learn about the latest results of pharmacological interventions for cognitive deficits. A final chapter focuses on the importance of addressing motivational deficits when treating cognition, and offers treatment approaches to enhance motivation. This publication is essential reading for clinicians and researchers in the fields of psychiatry, psychology as well as students and other professions working with people who have schizophrenia.
The Brain at Risk by Dawson Hedges,Thomas J. Farrer,Erin D. Bigler,Ramona O. Hopkins Pdf
This important book describes the effects of a range of medical, psychological, and neurological conditions on brain functioning, specifically cognition. After a brief introduction of brain anatomy and function focusing on neural systems and their complex role in cognition, this book covers common disorders across several medical specialties, as well as injuries that can damage a variety of neural networks. The authors review findings on associations between these conditions and cognitive domains such as executive function, memory, attention, and learning, and describe possible causal pathways between diseases and cognitive impairment. Later chapters describe potential strategies for prevention, improvement, and treatment. The book’s topics include Cognition in affective disorders Cerebrovascular disease and cognition Cognitive sequelae of sepsis Traumatic brain injury and cognition Cognitive deficits associated with drug use Obstructive sleep apnea and cognition Cognitive function in pulmonary disease The Brain at Risk reflects the current interest in the links between body, mind, and brain, and will be of great value to researchers and practitioners interested in neuroscience, neuropsychology, and clinical research in the cognitive and behavioral consequences of brain injury and disease.
National Academies of Sciences, Engineering, and Medicine,Institute of Medicine,Board on Health Sciences Policy,Forum on Neuroscience and Nervous System Disorders
Author : National Academies of Sciences, Engineering, and Medicine,Institute of Medicine,Board on Health Sciences Policy,Forum on Neuroscience and Nervous System Disorders Publisher : National Academies Press Page : 90 pages File Size : 52,5 Mb Release : 2015-10-29 Category : Medical ISBN : 9780309373968
Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression by National Academies of Sciences, Engineering, and Medicine,Institute of Medicine,Board on Health Sciences Policy,Forum on Neuroscience and Nervous System Disorders Pdf
Major depressive disorder (MDD) is recognized worldwide as a major cause of disability, morbidity, and mortality. According to the World Health Organization, unipolar depressive disorders affect more than 150 million people around the world and represent the leading cause of years lost due to disability among both men and women. In the United States alone, nearly 8 percent of persons over the age of 12 report current depression. MDD has long been defined primarily as a mood disorder. However,more recently people have begun to recognize effects on cognition as a major contributor to the disablement that accompanies depression and to consider this an underrecognized treatment target for depression. To explore how best to enable the discovery, development, and translation of treatments for cognitive dysfunction in depression, including a focus on the regulatory path forward, the Institute of Medicine's Forum on Neuroscience and Nervous Disorders convened key stakeholders at a workshop in February 2015. This report summarizes the presentations from expert speakers and discussions among workshop participants.
National Academies of Sciences, Engineering, and Medicine,Division of Behavioral and Social Sciences and Education,Committee on Population
Author : National Academies of Sciences, Engineering, and Medicine,Division of Behavioral and Social Sciences and Education,Committee on Population Publisher : National Academies Press Page : 409 pages File Size : 45,5 Mb Release : 2018-07-21 Category : Social Science ISBN : 9780309474108
Future Directions for the Demography of Aging by National Academies of Sciences, Engineering, and Medicine,Division of Behavioral and Social Sciences and Education,Committee on Population Pdf
Almost 25 years have passed since the Demography of Aging (1994) was published by the National Research Council. Future Directions for the Demography of Aging is, in many ways, the successor to that original volume. The Division of Behavioral and Social Research at the National Institute on Aging (NIA) asked the National Academies of Sciences, Engineering, and Medicine to produce an authoritative guide to new directions in demography of aging. The papers published in this report were originally presented and discussed at a public workshop held in Washington, D.C., August 17-18, 2017. The workshop discussion made evident that major new advances had been made in the last two decades, but also that new trends and research directions have emerged that call for innovative conceptual, design, and measurement approaches. The report reviews these recent trends and also discusses future directions for research on a range of topics that are central to current research in the demography of aging. Looking back over the past two decades of demography of aging research shows remarkable advances in our understanding of the health and well-being of the older population. Equally exciting is that this report sets the stage for the next two decades of innovative researchâ€"a period of rapid growth in the older American population.